Incidence of second primary malignancies in patients with treated head and neck cancer: A comprehensive review of literature

Current Medical Research and Opinion

Volumn 28, Issue 12, 2012, Pages 1899-1909

  Atienza, Jonessa Ann S ^a   Dasanu, Constantin A ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Cancer surveillance; Head and neck cancer; Metachronous second primary neoplasms; Second malignancies; Synchronous neoplasms

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIGALLOCATECHIN GALLATE; ISOTRETINOIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; RETINOL PALMITATE; SOMATOMEDIN C RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN RECEPTOR;

AGE; BRAIN CANCER; CANCER GENETICS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; DIGESTIVE SYSTEM CANCER; ENVIRONMENTAL FACTOR; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPOPHARYNX CANCER; IMMUNE DEFICIENCY; LARYNX CANCER; LIFESTYLE; LUNG CANCER; MOUTH CANCER; MYELOID LEUKEMIA; NON MELANOMA SKIN CANCER; NONHODGKIN LYMPHOMA; OROPHARYNX CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SECOND CANCER; SEX DIFFERENCE; TONGUE CANCER;

DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; META-ANALYSIS AS TOPIC; NEOPLASMS, SECOND PRIMARY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SURVIVAL RATE;

EID: 84870465954     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.746218     Document Type: Review

References (61)

1. A snapshot of head and neck cancer. National Cancer Institute, 2011. Available at: http://www.cancer.gov/aboutnci/servingpeople/cancer-statistics/ snapshots [Last accessed 30 June 2012]
2. Forte T, Niu J, Lockwood GA, Bryant HE. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009. Cancer Causes Control 2012;23:1343-8
3. Chuang SC, Scelo G, Tonita JM, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer 2008;123:2390-6
4. Tsou YA, Hua CH, Tseng HC, et al. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma. Acta Otolaryngol 2007;127:651-7
5. Priante AV, Castilho EC, Kowalski LP. Second primary tumors in patients with head and neck cancer. Curr Oncol Rep 2011;13:132-7
6. Day GL, Blot WJ, Shore RE, et al. Second cancers following oral and pharyn-geal cancers: role of tobacco and alcohol. J Natl Cancer Inst 1994;86:131-7
7. Lin K, Patel SG, Chu PY, et al. Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck 2005;27:1042-8
8. Lee KD, Lu CH, Chen PT, et al. The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period. BMC Cancer 2009;9:373
9. Peck BW, Dahlstrom KR, Gan SJ, et al. Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck 2012: published online 19 June 2012, doi:10.1002/hed.23033
10. Morris LG, Sikora AG, Hayes RB, et al. Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer. Cancer Causes Control 2011;22:671-9
11. Socié G, Scieux C, Gluckman E, et al. Squamous cell carcinomas after allo-geneic bone marrow transplantation for aplastic anemia: further evidence of a multistep process. Transplantation 1998;66:667-70
12. Wang Z, Sturgis EM, Zhang F, et al. Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squa-mous cell carcinoma of head and neck. Mol Cancer 2012;11:17
13. Hildebrandt MA, Lippman SM, Etzel CJ, et al. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention. Clin Cancer Res 2012;18:3705-13
14. Azad AK, Bairati I, Samson E, et al. Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers. Cancer 2012;118:1554-65
15. Bosetti C, Scelo G, Chuang SC, et al. High constant incidence rates of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries. Int J Cancer 2011;129:173-9
16. Rennemo E, Zätterström U, Boysen M. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2, 063 cases. Laryngoscope 2008;118:1350-6
17. Gao X, Fisher SG, Mohideen N, Emami B. Second primary cancers in patients with laryngeal cancer: a population-based study. Int J Radiat Oncol Biol Phys 2003;56:427-35
18. Warnakulasuriya KA, Robinson D, Evans H. Multiple primary tumours following head and neck cancer in southern England during 1961-98. J Oral Pathol Med 2003;32:443-9
19. Crosher R, McIlroy R. The incidence of other primary tumours in patients with oral cancer in Scotland. Br J Oral Maxillofac Surg 1998;36:58-62
20. Fijuth J, Mazeron JJ, Le Pé choux C, et al. Second head and neck cancers following radiation therapy of T1 and T2 cancers of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 1992;24:59-64
21. Kuss I, Hathaway B, Ferris R, et al. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res 2004;10:3755-62
22. Kuss I, Saito T, Johnson J, Whiteside T. Clinical significance of decreased z chain expression in peripheral blood lymphocytes of patients with head and neck cancer. Clin Cancer Res 1999;5:329-34
23. Haughey BH, Gates GA, Arfken CL, Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992;101:105-12
24. Spector JG, Sessions DG, Haughey BH, et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 2001;111:1079-87
25. Licciardello JT, Spitz MR, Hong WK. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys 1989;17:467-76
26. Chen MC, Chen PT, Chan CH, et al. Second primary esophageal or lung cancer in patients with head and neck carcinoma in Taiwan: incidence and risk in relation to primary index tumor site. J Cancer Res Clin Oncol 2011;137:115-23
27. Chu PY, Chang SY, Huang JL, Tai SK. Different patterns of second primary malignancy in patients with squamous cell carcinoma of larynx and hypo-pharynx. Am J Otolaryngol 2010;31:168-74
28. Parker RG, Enstrom JE. Second primary cancers of the head and neck following treatment of initial primary head and neck cancers. Int J Radiat Oncol Biol Phys 1988;14:561-4
29. Shiga K, Tateda M, Katagiri K, et al. Distinct features of second primary malignancies in head and neck cancer patients in Japan. Tohoku J Exp Med 2011;225:5-12
30. Fang P, Jiao S, Zhang X, et al. Meta-analysis of ALDH2 variants and esoph-ageal cancer in Asians. Asian Pac J Cancer Prev 2011;12:2623-7
31. Asakage T, Yokoyama A, Haneda T, et al. Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma. Carcinogenesis 2007;28:865-74
32. Scélo G, Boffetta P, Corbex M, et al. Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries. Cancer Causes Control 2007;18:269-78
33. Yamazaki H, Nakatogawa N, Ota Y, et al. Development of follicular lymphoma of the cervical lymph nodes in a postoperative patient with tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2012;113:e35-9
34. Caraway NP, Wojcik EM, Saboorian HM, Katz RL. Concomitant lymphoma and metastatic carcinoma in a lymph node: diagnosis by fine-needle aspiration biopsy in two cases. Diagn Cytopathol 1997;17:287-91
35. Millwaters M, Khan N, Halfpenny W. Simultaneous lymphoma and squamous cell carcinoma presenting as a neck lump. Br J Oral Maxillofac Surg 2008;46:144-5
36. Holland JM, Arsanjani A, Liem BJ, et al. Second malignancies in early stage laryngeal carcinoma patients treated with radiotherapy. J Laryngol Otol 2002;116:190-3
37. Milano MT, Peterson CR 3rd, Zhang H, et al. Second primary lung cancer after head and neck squamous cell cancer: population-based study of risk factors. Head Neck 2012: published online 9 February 2012, doi:10.1002/hed.22006
38. Jayaprakash V, Cheng C, Reid M, et al. Previous head and neck cancers portend poor prognoses in lung cancer patients. Ann Thorac Surg 2011;92:1056-60
39. Dequanter D, Shahla M, Lardinois I, et al. Second primary lung malignancy in head and neck cancer patients. Eur Ann Otorhinolaryngol Head Neck Dis 2011;128:11-13
40. Lee P, de Bree R, Brokx HA, et al. Primary lung cancer after treatment of head and neck cancer without lymph node metastasis: is there a role for autofluorescence bronchoscopy? Lung Cancer 2008;62:309-15
41. Hsu YB, Chang SY, Lan MC, et al. Second primary malignancies in squamous cell carcinomas of the tongue and larynx: an analysis of incidence, pattern, and outcome. J Chin Med Assoc 2008;71:86-91
42. Natsugoe S, Uchino Y, Kijima F, et al. Synchronous and metachronous carcinomas of the esophagus and head and neck. Dis Esophagus 1997;10:134-8
43. Di Martino E, Sellhaus B, Hausmann R, et al. Survival in second primary malignancies of patients with head and neck cancer. J Laryngol Otol 2002;116:831-8
44. Graff P, Schipman B, Desandes E, et al. Management of patients with head and neck tumours presenting at diagnosis with a synchronous second cancer at another anatomic site. Clin Oncol (R Coll Radiol) 2011;23:174-81
45. Manikantan K, Dwivedi RC, Sayed SI, et al. Current concepts of surveillance and its significance in head and neck cancer. Ann R Coll Surg Engl 2011;93:576-82
46. Ritoe SC, Krabbe PF, Jansen MM, et al. Screening for second primary lung cancer after treatment of laryngeal cancer. Laryngoscope 2002;112:2002-8
47. Stoeckli SJ, Zimmermann R, Schmid S. Role of routine panendoscopy in cancer of the upper aerodigestive tract. Otolaryngol Head Neck Surg 2001;124:208-12
48. Shaha AR, Hoover EL, Mitrani M, et al. Synchronicity, multicentricity, and metachronicity of head and neck cancer. Head Neck Surg 1988;10:225-8
49. Rodriguez-Bruno K, Ali MJ, Wang SJ. Role of panendoscopy to identify synchronous second primary malignancies in patients with oral cavity and oro-pharyngeal squamous cell carcinoma. Head Neck 2011;33:949-53
50. Paniello RC, Virgo KS, Johnson MH, et al. Practice patterns and clinical guidelines for posttreatment follow-up of head and neck cancers: a comparison of 2 professional societies. Arch Otolaryngol Head Neck Surg 1999;125:309-13
51. Joshi A, Calman F, O'Connell M, et al. Current trends in the follow-up of head and neck cancer patients in the UK. Clin Oncol (R Coll Radiol) 2010;22:114-18
52. Hong W, Lippman S, Itri L, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801
53. Jyothirmayi R, Ramadas K, Varghese C, et al. Efficacy of vitamin A in the prevention of loco-regional recurrence and second primaries in head and neck cancer. Eur J Cancer B Oral Oncol 1996;32B:373-6
54. Koch WM. Early Diagnosis and Treatment of Cancer Series: Head and Neck Cancer. Philadelphia: Saunders, 2010
55. Kim J, Amin A, Shin D. Chemoprevention of head and neck cancer with green tea polyphenols. Cancer Prev Res 2010;3:900-9
56. Masuda M, Wakasaki T, Toh S, et al. Chemoprevention of head and neck cancer by green tea extract: EGCG-the role of EGFR signaling and "lipid raft." J Oncol 2011: published online 2 January 2011, doi: 10.1155/2011/540148
57. Khariwala S, Carmella SG, Stepanov I, et al. Elevated levels of 1-hydroxypyr-ene and N'-nitrosonornicotine in smokers with head and neck cancer: a matched control study. Head Neck 2012: published online 17 July 2012, doi: 10.1002/hed.23085
58. Psyrri A, Sasaki C, Vassilakopoulou M, et al. Future directions in research, treatment and prevention of HPV-related squamous cell carcinoma of the head and neck. Head Neck Pathol 2012;6(Suppl 1):121-8
59. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Nat Cancer Inst 2000;92:709-20
60. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol Off J Am Soc Clin Oncol 2006;24:736-47
61. Chen AM, Phillips TL, Lee NY. Practical considerations in the re-irradiation of recurrent and second primary head-and-neck cancer: who, why, how, and how much? Int J Radiat Oncol Biol Phys 2011;81:1211-19